ObjectiveTo Investigate the cervical cancer patients' knowledge and situation concerniug cervical cancer screening and explore the connection of cervical cancer screening status and clinical stage at diagnosis of cervical lesions.MethodsQuestionnaires were done for the cervical cancer patients who went to Peking University People's Hospital from February 2010 to October 2011.The patient's age,first visit or not,cause for treatment,awareness of cervical cancer now as well as that before diagnosis of the disease,the last cervical cancer screening' time and the clinical stage were recorded.The results of questionnaires were analyzed with SPSS 16.0.Results(1) One hundred and thirty-eight cases were collected and the average age was (48 ± 10) years old.Concerning the awareness level,the patients were divided into three groups of 10 points,5 points and 0 point based on the score of the second parts of the questionnaires.The number of the patients of the above three groups were 114 ( 82.6％ ),18 ( 13.0％ ) and 6 (4.3％ ) at present,while before the cancer diagnosis the number of the patients of the above three groups were 5 (3.6％),13 (9.4％) and 120 (87.0％).Patient's awareness level was much higher now than that before the cancer diagnosis(P ＜0.05 ).(2) Based on the last cervical cancer screening time,the patients were divided into four groups including within one year ( group 1 ),a year ago but within three years ( group 2),three years ago (group 3) and never done (group 4).There were 9 (6.5％) cases in group 1,30 (21.7％) cases in group 2,29 (21.0％) cases in group 3 and 70 ( 50.7％ ) cases in group 4.There were 5 (5/9)cases with stage Ⅰ a,3 (3/9)cases with stage Ⅰ b and 1 ( 1/9)case with stage Ⅱ or above in group 1;11 (36.7％,11/30) cases with stage Ⅰ a,15 (50.0％,15/30) cases with stage Ⅰ b and 4 (13.3％,4/30) cases with stage Ⅱ or above in group 2;5 (17.2％,5/29) cases with stage Ⅰ a,14 (48.3％,14/29 ) cases with stage Ⅰ b was and 10 ( 34.5％,10/29 )cases with stage Ⅱ or above in group 3;7 (10.0％,7/70) cases stage with Ⅰ a,35 (50.0％,35/70) cases with stage Ⅰ b and 28 (40.0％,28/70) cases with stage Ⅱ or above in group 4.The results showed that there was an increasing trend of advanced cervical carcinoma at diagnosis for the patients with longer last cervical cancer screening time (P ＜0.05 ).ConclusionsPeople's awareness level is much higher after being educated in cervical cancer.Among the cervical cancer patients,the probability of diagnosed patients with advanced cervical cancer has an increasing trend when their screening situation is poor.To raise the screening attendance rate among appropriate women,we should spread knowledge of cervical cancer to the population.

It is reported that zymogen granule membrane glycoprotein 2 (GP2 )and CUB and zona pellucida-like domain-containing protein 1 (CUZD1 )are the major autoantigens of autoantibodies against exocrine pancreas (PAB).GP2 is mainly expressed in the pancreatic acinar cell and M cells in small intestine follicle-associated epithelium,and CUZD1 is mainly expressed in uterus,ovary and pancreatic acinar cell.PAB is a relatively specific antibody for Crohn's disease (CD).The article reviewed the progress in study on autoantigens of PAB in CD.

31 rat were divided randomly into control group (n=10),tripterygium wilfordii glycosides group (n = 10 9. 4 mg/kg per day),and poly saccharide sulphate group (n=11. 30 mg/per day). We made balloon endothelium denudation in thoracic aortae of the rats. The treatments with drugs began 6 days before balloon injury and continously until the animal were killed 14 day after balloon injury. The determinations for area of neointima, neointima /media, coverage of neointima and 3H-TdR incoperation of thoracic aortae suggested that tripterygium wilfordii glycosides can inhibit intimal proliferation of injuried aorta, whill poly saccharide sulphate shows no effect.

0 05) The radiotherapy and chemotherapy ratio of them was significantly higher than the control ( P 0 05). Multivariate analysis showed that the prognosis were related to the stage and tumor cell differentiation affected the prognosis remarkable But the prognosis was independent of age and associated medical disorders Conclusions The endometrial carcinoma often associates with hypertension, diabetes mellitus, coronary heart disease, and so on The incidence rate of medical disorders increases with the aging of the patients The medical disorders might affect the therapy to a certain extent But they do not affect the prognosis remarkably

Objective To study the effects of nifedipine and mibefradil on the cell proliferation,apoptosis,migration on the HEC-1 A in vitro and also study the mRNA and protein expression levels of the calcium channel alpha1 D( Cav1.3 ) and calcium channel alpha1G (Cav3.1 ) to discuss the effects of the calcium antagonists on the mechanisms of the endometrial carcinoma.Methods ( 1 ) Add 10 μmol/L nifedipine and mibefradil at 15 minutes before adding 10 μmol/L 17β-estradiol( 17β-E2 ) and 100 μmol/L b-estradiol-6-(O-carboxymethyl) oxime(E2-BSA) to the HEC-1A in different time including 0,5,15,30,60,120 minutes.Then the changes of mRNA and protein were detected by reverse transcripiton( RT)-PCR and western-blot.(2)Add 1.25,2.5,5,10,20,40,80,100 μmol/L nifedipine and mibefradil to the HEC-1 A at 24,48,96 hours to detect the cell proliferation by 3-( 4,5 )-dimethylthiahiazo (-z-y1)-3,5-diphenytetrazoliumromide (MTT) method.(3) Add 10 μmol/L nifedipine and mibefradil to the HEC-1A,then detect the apoptosis at 0 minute,30 minutes,1 hour,6 hours,24 hours and migration in vitro at 36 hours with transwell methods.Results ( 1 ) After the pretreated effect of the nifedipine before 17β-E2,the mRNA express of Cav1.3 genes was lowest at 15 minutes,and returned to the control level after 30 minutes.The protein level didn't change very much in 30 minutes,but rose after 60 minutes.The Cav3.1 genes mRNA express was lowest at 5 minutes,rose at 30 minutes and returned to the 0 minute level gradually.(2) After the pretreated effect of the nifedipine before E2-BSA,the Cav1.3 genes mRNA was lowest at 5 minutes and returned at 15 minutes.The protein level rose gradually in 15 minutes but reduced after 15 minutes.The Cav3.1 mRNA and protein level were reduced at every time point.(3) After the pretreated effect of the mibefradil before 17β-E2,there was no change of mRNA expression of Cav1.3 genes.The protein level rose at 15 and 60 minutes,there was no change in any other time.The Cav3.1 genes mRNA were gradually reduced and the protein level rose at 15 minutes,and there was no change in any other times.(4) After the pretreated effect of the mibefradil before E2-BSA,the mRNA and protein of Cav1.3 levels were reduced after 15 minutes.There was no mRNA expression of Cav3.1,while the protein level was lowest at 15 minutes.(5)Nifedipine and mibefradil affected HEC-1A proliferation depended on the different concentration and interval time points.There was significant difference than those in control group ( P ＜ 0.05 ).( 6 ) There were statistical differences in apoptosis rate after adding nifedipine ( P ＜ 0.05 ),while rose at mibefradil treated the same time ( 24 hours:8.41 ± 0.07,0 minute:3.74 ± 0.18 ; P ＜ 0.05 ).(7) The numbers of stained cells after both nifedipine and mibefradil treated reduced more than control group.Conclusions ( 1 ) Nifedipine and mibefradil could inhibit both the effect of the estrogen on the L-type and T-type calcium channel in short time,meanwhile the mibefradil effects last long time. (2) The inhibited effect of the mibefradil on the proliferation,apoptosis and migration of HEC-1A cells in vitro is more significant than that by nifedidipine.

Objective To evaluate the relationship of small heterodimer partner(SHP) gene and birth weight in China. Methods A cohort study of 191 normal pregnant women was conducted. Both maternal and cord blood samples were collected. PCR-RFLP was used to detect the polymorphism of SNP-rs7504 of SHP. Results (1) The frequency of both neonatal and maternal C allele and (TC+CC) genotype increased significantly with birth weight (P=0.004, OR=3.168; P=0.005, OR=3.315; P=0.013, OR=2.495; P=0.013, OR=2.495). (2) The babies were heavier if they were C allele carrier. The average increase of birth weight was 246.3 g comparing the neonates with TC+CC genotype with those with TT genotype [(3658.7?400.94)g vs (3412.4?444.4)g, P=0.005]. The average birth weight of those maternal C allele carriers was 210.3 g heavier than those non-C allele carriers[(3628.9?405.5) g vs (3418.6?449.0 g]. (3) The fetal C allele was associated with maternal weight in pregnancy, prepregnant BMI, paternal height and weight. Women with C allele were heavier and had higher BMI without statistical significance comparing with those non-C allele carriers. Neither neonatal nor maternal SHP gene was associated with blood glucose and insulin level. (4) Multiple factors analysis showed that birth weight was related to maternal height, weight gain during pregnancy, prepregnant BMI, maternal and cord blood insulin level. After adjustment, the neonatal birth weight remained significantly correlated with cord blood SHP (P=0.0354), but not with maternal SHP gene (P=0.0711). Conclusions SHP gene is associated with newborns birth weight and may affect fetal growth.

Objective To retrospectively analyze the efficacy of a pediatric treatment protocol,BFM90,in adult patients with acute lymphobiastic leukemia (ALL) up to the age of 60 years. Methods From August 2004 to October 2007,60 adult patients (median age,40 years; range,18 to 60 years) with Philadelphia chromosome-negative ALL were treated with the BFM90 protocol. Clinical effect were historically compared with that of the 35 patients (median age,42 years; range,18 to 56 years) who were treated with Hyper-CVAD protocol. Results At 42 months,complete remission (CR) rate,event-free survival (EFS) and overall survival (OS) rates were 93 % (56 patients),60 % (36 patients) and 65 % (39 patients),respectively.Age is an important prognostic factor,with 45 years of age as best cutoff. CR (P=0.02),OS (P ＜0.001),and EFS (P ＜0.001) of BFM90 were compared superiorly with that of the previous Hyper-CVAD experience.Conclusion These results suggest that pediatric protocol superior to the outcome of adult patients with Philadelphia chromosome-negative ALL.

Objective To compare the expressions of p16~(ink4a) and Ki-67 in human cervical lesions. Methods The expressions of p16~ink4a and Ki-67 protein were measured with immunhistochemical staining in 42 human normal uterine cervical tissues,21 with human cervical intraepitheial neoplasia(CIN) Ⅰ,21 with CINⅡ,and 36 with CINⅢ.The relevance of the expressions of the two proteins to CIN grades was analyzed by Spearman Correlation.The sensitivity,specificity,positive/negative predictive values,and youden's index of p16~(ink4a) and Ki-67 were also studied. Results For p16~(ink4a),the sensitivity and specificity were 83.3% and 90.5%;the positive and negative predictive values were 94.2% and 74.5%;Youden's index was 0.738.For ki-67,the sensitivity and specificity were 98.7% and 16.7%;the positive and negative predictive values were 68.75% and 87.5%;Youden's index was 0.154.Both the sensitivity and specificity for the combined Ki-67 and p16~(ink4a) are 83.3%.Conclusion p16~(ink4a) has higher specificity and positive predictive value,and is a good diagnostic marker for cervical lesion.By contrast,Ki-67 has higher sensitivity and negative predictive value.Even with its poor specificity,it can still be regarded as a supplementary test for early diagnostic cervical lesion.The overall performance of p16~(ink4a) is better than that of Ki-67.

Repeated calcium depletion and repletion of short term duration Ca2+ preconditioning CPC is hypothesized to protect the heart from lethal injury after exposing it to the Ca2+ paradox (Ca2+ PD). Hearts were preconditioned with five cycles of Ca2+ depletion (1 minute) and Ca2+ repletion (5 minutes). These hearts were then subjected to Ca2+ PD,ie,one cycle of Ca2+ depletion (ten minutes) and Ca2+ repletion (ten minutes). Hearts subjected to the Ca2+ PD underwent rapid and severely injury. CPC showed remarkable protection against the Ca2+ PD injury. Protein release from the perfusated heart was significantly reduced in CPC hearts compared with nopreconditioned Ca2+ PD hearts (0. 56 + 0. 10 and 1. 23 + 0. 10 mg/ml respectively ,P

There were no data concerning restenosis rate after percutaneous transluminal coronary angio-plasty available in China so far. Our study was focused on clinical and angiographic follow-up and tried to reveal the predictive value for angiographic restenosis using noninvasive tests among 592 patients whose 841 coronary arteries were dilated in our department from Dec. 1987 to Dec. 1994.This patient group consisted of 503 males and 89 females had average age of 58. 4 ? 9. 1. The overall success rate was 93. 3% and acute vessel complications was 4. 1%. After successful procedures of PTCA,the patients were followed up with recurrence of angina, Holler ECG, submaximal excercise ECG and 99mTc-MIBI exercise scintigraphy regularly. 62 of these patients underwent coronary angiographic follow-up from 4-24 months (average time: 10. 4 ? 7. 6 months) after PTCA. We found 35 patients with angiographic restenosis and 27 patients without. Thus, we divided the patients into restenosis group and non-restenosis group according to the angiographic results. Subsequently, we oberserved whether the symptom and noninvasive tests were valuable in prediction of restenosis. The result showed that recurrence of angina, Holter ECG, submaximal exercise ECG and 99mTc-MIBI scintigraphy were useful in detecting restenosis with their specificity and sensitivity 75.7% and 72.0%, 71. 4% and 86. 7%, 66. 7% and 73. 1% ,76. 5% and 83. 3 %, respectively. Moreover, If any two of above four ischemic indexes were combined together to detect restenosis,the specificity and sensitivity were significantly enhanced (85. 2% and 92. 9%). It is concluded that recurrence of angina and the noninvasive tests were valuable in predicting restenosis. The combination of these ischemic indexes would greatly improve their predictive value.